Curanex Pharmaceuticals Inc (CURX) News
Follow Curanex Pharmaceuticals Inc (CURX) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 5 public stories across 4 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Curanex regains Nasdaq compliance after reverse stock split
Curanex Pharmaceuticals regained Nasdaq compliance after a 1-for-20 reverse stock split restored its $1.00 minimum bid price.
REGULATION | Sep 04, 2026, 08:24 PM UTC
L
CURX schedules 1-for-20 reverse stock split for Aug 20
CURX is set to execute a 1-for-20 reverse stock split on Thursday, Aug 20, according to TradeXchange Newsdesk.
REGULATION | Aug 20, 2026, 09:04 AM UTC
M
Curis plans 1-for-20 reverse stock split Thursday
Curis (CURX) is listed for a 1-for-20 reverse stock split on Thursday Aug. 20.
EQUITY | Aug 19, 2026, 08:44 PM UTC
M
Curis announces 1-for-20 reverse stock split
Curis (CURX) has a 1-for-20 reverse stock split scheduled for Thursday, Aug. 20.
EQUITY | Aug 19, 2026, 02:47 PM UTC
L
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Abivax (NASDAQ: ABVX ) shares increased by 36.0% to $130.74 during Tuesday's pre-market session. The company's market cap stands at $7.6 billion. Cuprina Holdings (Cayman) (NASDAQ: CUPR ) shares moved upwards by
EQUITY | Jun 30, 2026, 12:05 PM UTC